Michiels, Y.; Houhou-Fidouh, N.; Collin, G.; Berger, J.; Kohli, E.
Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis Patient. Vaccines 2021, 9, 1140.
https://doi.org/10.3390/vaccines9101140
AMA Style
Michiels Y, Houhou-Fidouh N, Collin G, Berger J, Kohli E.
Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis Patient. Vaccines. 2021; 9(10):1140.
https://doi.org/10.3390/vaccines9101140
Chicago/Turabian Style
Michiels, Yves, Nadhira Houhou-Fidouh, Gilles Collin, Jérôme Berger, and Evelyne Kohli.
2021. "Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis Patient" Vaccines 9, no. 10: 1140.
https://doi.org/10.3390/vaccines9101140
APA Style
Michiels, Y., Houhou-Fidouh, N., Collin, G., Berger, J., & Kohli, E.
(2021). Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis Patient. Vaccines, 9(10), 1140.
https://doi.org/10.3390/vaccines9101140